{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:27:14Z","timestamp":1781220434944,"version":"3.54.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0241649","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T18:37:07Z","timestamp":1604342227000},"page":"e0241649","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem"],"prefix":"10.1371","volume":"15","author":[{"given":"Wenbo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily H.","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah G.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Juno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-4891","authenticated-orcid":true,"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"issue":"1","key":"pone.0241649.ref001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"F Krammer","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"pone.0241649.ref002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-020-0626-6","article-title":"Better influenza vaccines: an industry perspective","volume":"27","author":"JR Chen","year":"2020","journal-title":"J Biomed Sci"},{"key":"pone.0241649.ref003","article-title":"Past seasons vaccine effectiveness estimates","author":"Centers for Disease Control and Prevention","journal-title":"Adjusted vaccine effectiveness estimates for influenza seasons from 2004\u20132018"},{"key":"pone.0241649.ref004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coviro.2020.02.003","article-title":"Tracking progress in universal influenza vaccine development","volume":"40","author":"J Ostrowsky","journal-title":"Curr Opin Virol. 2020"},{"key":"pone.0241649.ref005","volume-title":"Fields Virology","author":"M David","year":"2013","edition":"6"},{"key":"pone.0241649.ref006","volume-title":"Textbook of Influenza","author":"G Robert","year":"2013","edition":"2"},{"key":"pone.0241649.ref007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"N Pica","year":"2013","journal-title":"Annu Rev Med"},{"key":"pone.0241649.ref008","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","article-title":"Is a Universal Influenza Virus Vaccine Possible?","volume":"71","author":"R Nachbagauer","year":"2020","journal-title":"Annu Rev Med."},{"issue":"3","key":"pone.0241649.ref009","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"J Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"pone.0241649.ref010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI123366","article-title":"Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem","volume":"129","author":"HX Tan","year":"2019","journal-title":"J Clin Invest"},{"key":"pone.0241649.ref011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fmicb.2020.00135","article-title":"Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics","volume":"11","author":"OA Vogel","year":"2020","journal-title":"Front Microbiol."},{"key":"pone.0241649.ref012","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fimmu.2018.00598","article-title":"Distinct Immunologic Properties of Soluble Versus Particulate Antigens","volume":"9","author":"CM Snapper","year":"2018","journal-title":"Front Immunol."},{"key":"pone.0241649.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"DJ Irvine","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"pone.0241649.ref014","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"HM Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"3","key":"pone.0241649.ref015","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"AS Rosenberg","year":"2006","journal-title":"AAPS J."},{"issue":"1\u20132","key":"pone.0241649.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2012.04.040","article-title":"Immunogenicity of protein aggregates\u2014concerns and realities","volume":"431","author":"W Wang","year":"2012","journal-title":"Int J Pharm"},{"issue":"5","key":"pone.0241649.ref017","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jps.20599","article-title":"Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation","volume":"95","author":"S Hermeling","year":"2006","journal-title":"J Pharm Sci"},{"issue":"26","key":"pone.0241649.ref018","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.vaccine.2008.03.078","article-title":"Adjuvant potential of aggregate-forming polyglutamine domains","volume":"26","author":"PO Ilyinskii","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"pone.0241649.ref019","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1128\/JVI.00187-08","article-title":"Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus","volume":"82","author":"CJ Wei","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"pone.0241649.ref020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41591-020-0753-3","article-title":"Engineered immunogen binding to alum adjuvant enhances humoral immunity","volume":"26","author":"TJ Moyer","year":"2020","journal-title":"Nat Med"},{"issue":"15\u201316","key":"pone.0241649.ref021","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.vaccine.2003.10.040","article-title":"Distribution of adsorbed antigen in mono-valent and combination vaccines","volume":"22","author":"GL Morefield","year":"2004","journal-title":"Vaccine"},{"key":"pone.0241649.ref022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"H HogenEsch","year":"2018","journal-title":"NPJ Vaccines"},{"key":"pone.0241649.ref023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jim.2019.02.008","article-title":"Identification of murine antigen-specific T follicular helper cells using an activation-induced marker assay","volume":"467","author":"W Jiang","year":"2019","journal-title":"J Immunol Methods"},{"issue":"10","key":"pone.0241649.ref024","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136653","article-title":"Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation","volume":"5","author":"HG Kelly","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"pone.0241649.ref025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A self-assembling peptide acting as an immune adjuvant","volume":"107","author":"JS Rudra","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"pone.0241649.ref026","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1016\/j.vaccine.2010.08.054","article-title":"HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen","volume":"28","author":"R Saenz","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"pone.0241649.ref027","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/CVI.00714-14","article-title":"Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice","volume":"22","author":"RF Grenfell","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"44","key":"pone.0241649.ref028","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1016\/j.vaccine.2011.07.133","article-title":"Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine","volume":"29","author":"JC Jones","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"pone.0241649.ref029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4161\/mabs.1.3.8035","article-title":"Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies","volume":"1","author":"X Wang","year":"2009","journal-title":"MAbs"},{"issue":"22","key":"pone.0241649.ref030","doi-asserted-by":"crossref","first-page":"11910","DOI":"10.1073\/pnas.97.22.11910","article-title":"A census of glutamine\/asparagine-rich regions: implications for their conserved function and the prediction of novel prions","volume":"97","author":"MD Michelitsch","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pone.0241649.ref031","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tips.2009.11.001","article-title":"Immunological mechanism underlying the immune response to recombinant human protein therapeutics","volume":"31","author":"M Sauerborn","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"pone.0241649.ref032","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"TJ Moyer","year":"2016","journal-title":"J Clin Invest"},{"key":"pone.0241649.ref033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40064-015-0972-0","article-title":"The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm","volume":"4","author":"TR Ghimire","year":"2015","journal-title":"Springerplus"},{"key":"pone.0241649.ref034","doi-asserted-by":"crossref","first-page":"3974127","DOI":"10.1155\/2019\/3974127","article-title":"Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants","volume":"2019","author":"S Martinon","year":"2019","journal-title":"J Immunol Res"},{"issue":"2","key":"pone.0241649.ref035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"P He","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"pone.0241649.ref036","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"MF Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"pone.0241649.ref037","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.90.11.4942","article-title":"Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages","volume":"90","author":"M Kovacsovics-Bankowski","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0241649.ref038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"R Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"pone.0241649.ref039","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","article-title":"Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies","volume":"28","author":"A Jegerlehner","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"pone.0241649.ref040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/08923973.2016.1165246","article-title":"The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines","volume":"38","author":"MJ McCluskie","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"34","key":"pone.0241649.ref041","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: A review","volume":"28","author":"R Dagan","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"pone.0241649.ref042","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s40265-013-0103-6","article-title":"Recombinant trivalent influenza vaccine (flublok((R))): a review of its use in the prevention of seasonal influenza in adults","volume":"73","author":"LP Yang","year":"2013","journal-title":"Drugs"},{"issue":"4","key":"pone.0241649.ref043","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2051013615595595","article-title":"Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults","volume":"3","author":"MM Cox","year":"2015","journal-title":"Ther Adv Vaccines"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T18:37:29Z","timestamp":1604342249000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241649"}},"subtitle":[],"editor":[{"given":"Victor C.","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0241649","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]}}}